Hormonal hypertension in children: 11β-hydroxylase deficiency and apparent mineralocorticoid excess

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 9, 2000, Pages 1537-1547

  Cerame, B I ^a   New, M I ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

11 hydroxylase deficiency; 11 hydroxysteroid dehydrogenase type 2 (11 HSD2); Apparent mineralocorticoid excess; Children; CYP11B1; HSD11B2; Hypertension

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID; POTASSIUM; RENIN; STEROID 11BETA MONOOXYGENASE;

AUTOSOMAL RECESSIVE DISORDER; CHILDHOOD DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENZYME DEFICIENCY; HORMONE RELEASE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; PATHOPHYSIOLOGY; PRENATAL DIAGNOSIS; REVIEW;

EID: 0034520495     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.9.1537     Document Type: Review

References (45)

1. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
2. Disorders of steroid 11β-hydroxylase isozymes
3. High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco
4. Hypertension in a neonate with 11 beta-hydroxylase deficiency
5. Characterization of urinary steroids in adrenal hyperplasia: Isolation of metabolites of cortisol, compound S, and deoxycorticosterone from a normotensive patient with adrenogenital syndrome
6. Urinary steroids in the hypertensive form of congenital adrenal hyperplasia
7. Die beta-Ketolischen Cortisol und Corticosteronmetaboliten sowie die 11-Oxy-und 11-Desoxy-17-ketosteroide im Urin von Kindern
8. Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency: Final diagnosis in adult age in three patients
9. The human gene mutation database
10. Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency
11. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol
12. A mutation in CYP11B1 (Arg-448→His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin
13. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency)
14. Extensive personal experience: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency
15. Familial congenital adrenal hyperplasia caused by 11 beta-hydroxylase. Failure of prevention of sexual ambiguity and prenatal diagnosis
16. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8
17. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency
18. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia
19. Unusual steroid excretion in a child with low-renin hypertension
20. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension
21. An abnormality in steroid reductive metabolism in a hypertensive syndrome
22. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
23. A genetic defect resulting in mild low-renin hypertension
24. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion
25. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system
26. Renal capture and oxidation of cortisol in man
27. Extensive personal experience: Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess
28. Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex
29. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
30. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency
31. 11 Beta-hydroxysteroid dehydrogenase in renal collecting duct cells
32. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme
33. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess
34. Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess
35. Human hypertension caused by mutations in the kidney isozyme of 11 β-hydroxysteroid dehydrogenase
36. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 β-hydroxysteroid dehydrogenase type 2 gene
37. A new compound heterozygous mutation in the 11 β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess
38. Apparent mineralocorticoid excess in a Brazilian kindred: Hypertension in the heterozygote state
39. Molecular basis for hypertension in the "type 11 variant" of apparent mineralocorticoid excess